MBIO Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
1.1M
-9.6%
1.2M
+10.6%
1.1M
+57.9%
670.0K
+7.4%
624.0K
R&D
208.0K
-7.1%
224.0K
+25.8%
178.0K
+156.2%
-317000
+4.8%
-333000
SG&A
850.0K
-10.1%
946.0K
+7.5%
880.0K
-10.8%
987.0K
+3.1%
957.0K
Operating Income
-1058000
+9.6%
-1170000
-10.6%
-1058000
-57.9%
-670000
-7.4%
-624000
EBITDA
-1058000
+9.6%
-1170000
-10.6%
-1058000
-57.9%
-670000
-7.4%
-624000
Net Income
-964000
+10.1%
-1072000
-12.3%
-955000
-77.5%
-538000
-15.0%
-468000
EPS (Basic)
$-0.14
+12.5%
$-0.16
-14.3%
$-0.14
-75.0%
$-0.08
-14.3%
$-0.07
EPS (Diluted)
$-0.14
+12.5%
$-0.16
-14.3%
$-0.14
-75.0%
$-0.08
-14.3%
$-0.07
Shares (Diluted)
6.7M
+0.0%
6.7M
+0.0%
6.7M
+3.4%
6.5M
+4.3%
6.2M
Mustang Bio (MBIO) — Financials